earnings came in ahead of analysts’ expectations. The medical device maker said it expects its revenue growth to accelerate as it looks to regain momentum after earnings misses which sank the stock last year. 


(ticker: MDT), which Barron’s wrote as a stock pick earlier this year, reported adjusted per-share earnings of $1.30 for the quarter to Jan 27. Sales came to $7.73 billion, up 4.4% from the prior year on a constant-currency basis.  


Source link